swamplink

← Counting Cats & Whiskers · all breeds

Persian cat

origin: Iran · 34 figures in the corpus · Q42610

Every figure below carries this breed's name or id in its source study -- grouped by what it measures, not ranked. A breed appearing under a study here does not mean every other breed was tested and came back negative; it means this is what has a named source so far. See each figure's own page for its caveats.

Longevity

10.93 years (life expectancy at age 0) verified

Persian: years (life expectancy at age 0) (Teng KT, O'Neill DG, Brodbelt DC, Church DB, Pegram C)

  • Study sample n=80.
14.1 years (median age at death) verified

Persian: years (median age at death) (O'Neill DG, Church DB, McGreevy PD, Thomson PC, Brodbelt DC)

  • Study sample n=70.

Causes of death

627 deaths per 10,000 cat-years at risk (ASMR) verified

Persian group: age-standardized total mortality rate, Swedish insured cats (Egenvall 2009, Agria)

  • A rate, not a life expectancy -- higher ASMR means higher yearly death risk, not necessarily a shorter median lifespan.
  • Breed label 'Persian group' does not map 1:1 onto a single roster breed.
10.8 percent stillborn verified

Persian: stillbirth rate, UK pedigree litters (Sparkes et al. 2006)

  • Study sample n=212 litters.
14.5 percentage points dead between birth and 8 weeks verified

Persian: birth-to-8-week kitten mortality, UK pedigree litters (Sparkes et al. 2006)

  • Study sample n=212 litters.

Breeding

3.34 mean kittens per litter verified

Exotic/Persian: mean litter size (Cerna et al. 2024)

  • Study sample n=44 litters.
  • Study breed label 'Exotic/Persian' pools variants or does not map 1:1 onto a single roster breed (e.g. joint shorthair/longhair or joint-breed labels in the source table).
2.3 percent of litters by caesarean section verified

Exotic/Persian: caesarean-section rate (Cerna et al. 2024)

  • Study sample n=44 litters.
  • Study breed label 'Exotic/Persian' pools variants or does not map 1:1 onto a single roster breed (e.g. joint shorthair/longhair or joint-breed labels in the source table).
15.6 percent cumulative kitten mortality to 12 weeks verified

Exotic/Persian: cumulative kitten mortality to 12 weeks, stillbirths included (Cerna et al. 2024)

  • Study sample n=44 litters.
  • Study breed label 'Exotic/Persian' pools variants or does not map 1:1 onto a single roster breed (e.g. joint shorthair/longhair or joint-breed labels in the source table).

Bodyweight

3.5 kg (adult bodyweight, Wikidata P2067) verified

Persian cat: adult bodyweight

  • Wikidata mass is sparse and its own sourcing varies by item; treat as indicative, not a veterinary measurement. See bodyweight-vetcompass-* figures for breeds with a clinical-cohort measurement instead.
3.9 kg (mean adult bodyweight, VetCompass UK) verified

Persian: adult bodyweight (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • SD 0.9 kg.
  • Study sample n=3235 Persians.

Category (FIFe)

1 FIFe category (1-4, coat/morphology grouping) verified

Persian (PER): FIFe Category 1

  • Category is a coat/morphology grouping FIFe itself uses, not a ranking (1=lowest number, 4=highest, no ordinal meaning).

Disorders

12.7 percent of Persians with the disorder recorded verified

Persian: Haircoat disorder prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 11.6-13.9%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
5.8 percent of Persians with the disorder recorded verified

Persian: Ocular discharge prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 5.0-6.7%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
5.8 percent of Persians with the disorder recorded verified

Persian: Heart murmur prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 5.0-6.7%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
5.1 percent of Persians with the disorder recorded verified

Persian: Fleas infestation prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 4.4-5.9%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
4.9 percent of Persians with the disorder recorded verified

Persian: Weight loss prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 4.2-5.8%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
4.5 percent of Persians with the disorder recorded verified

Persian: Conjunctivitis prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 3.8-5.3%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
4.4 percent of Persians with the disorder recorded verified

Persian: Diarrhoea prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 3.7-5.2%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
4.3 percent of Persians with the disorder recorded verified

Persian: Vomiting prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 3.7-5.1%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
3.6 percent of Persians with the disorder recorded verified

Persian: Chronic renal failure prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 3.0-4.3%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
3.2 percent of Persians with the disorder recorded verified

Persian: Underweight prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 2.6-3.8%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
2.5 percent of Persians with the disorder recorded verified

Persian: Otitis externa prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 2.0-3.1%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
2.5 percent of Persians with the disorder recorded verified

Persian: Sneezing prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 2.0-3.1%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
2.3 percent of Persians with the disorder recorded verified

Persian: Tear duct abnormality prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.9-2.9%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
2.3 percent of Persians with the disorder recorded verified

Persian: Ulcerative keratitis prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.9-2.9%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
2.0 percent of Persians with the disorder recorded verified

Persian: Polyuria/polydipsia prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.6-2.6%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
1.9 percent of Persians with the disorder recorded verified

Persian: Corneal disorder prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.4-2.4%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
1.8 percent of Persians with the disorder recorded verified

Persian: Cystitis prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.3-2.3%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
1.7 percent of Persians with the disorder recorded verified

Persian: Nasal discharge prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.3-2.2%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
1.6 percent of Persians with the disorder recorded verified

Persian: Upper respiratory tract disorder prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.2-2.1%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
1.5 percent of Persians with the disorder recorded verified

Persian: Upper respiratory tract infection prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.1-2.0%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.
1.5 percent of Persians with the disorder recorded verified

Persian: Trichobezoar (hairball) prevalence (VetCompass, Fuentes Pachon C, O'Neill DG, Faroon A, Church DB, Brodbelt DC)

  • 95% CI 1.1-1.9%. Breed sample n=3235 out of a 285,547 cat VetCompass cohort.

HCM/PKD

49.0 percent (autosomal dominant polycystic kidney disease) preliminary

Persian: Autosomal dominant polycystic kidney disease (ADPKD) prevalence, 1996-2000 UK screening cohort (as cited in Fuentes Pachon et al. 2019)

  • Cohort: UK, high-risk Persians (screening referrals, not a general population sample). This is a secondhand citation within the fetched paper, not independently re-verified against the original 1996-2000 screening study by this project. See also pkd-prevalence-persian-iran2022 for a directly-fetched primary molecular estimate.
46.8 percent (PKD1 c.10063C>A heterozygous carriers) preliminary

Persian and Persian-related breeds (Iran): Autosomal dominant polycystic kidney disease (ADPKD), PKD1 c.10063C>A carrier prevalence

  • 22/47 cats positive. Convenience sample of cats presented for testing in Iran, not a random general-population sample; 'Persian-related breeds' pooled with Persian, not broken out.